"Specialized in Gut Health 'MPRO4' Surpasses 200 Million Units Sold"

Over 4 Years and 4 Months Since Its 2019 Launch
Cumulative Sales Surpass 400 Billion Won

hy announced on the 14th that its premium probiotics 'MPRO4 2 types' have surpassed a cumulative sales volume of 200 million units and exceeded 400 billion KRW in revenue. This milestone was achieved 4 years and 4 months after its launch in February 2019.

hy Premium Probiotics 'MPRO4' 2 Types
Photo by hy

MPRO4 is a gut health-specialized product that consolidates hy's technological expertise. 'M' stands for Microbiome, 'PRO' is an abbreviation for Probiotics, and '4' represents the number of patented strains contained in the product.

This product was developed after over four years of research from the initial planning stage to human application trials. In 2022, through a renewal, the patented strain 'HY7715' with strong intestinal survival was additionally incorporated to enhance functionality. The product name was also changed from 'Gut Care Project MPRO3' to the current brand.

The biggest feature of MPRO4 is its dual formulation. It is the first in Korea to combine probiotic capsules and liquid prebiotics in one bottle. Both types are health functional foods. The prebiotics, which help the proliferation of lactic acid bacteria, contain up to 3,700 mg.

Shin Sang-ik, head of the M&S division, stated, "'MPRO4' is a product that has quickly established itself in the market, recognized as a representative probiotic in Korea," and added, "We will lead the popularization of functional probiotics based on continuous research."

This content was produced with the assistance of AI translation services.